Shares of Biohaven Pharmaceutical (NYSE: BHVN) closed up 20% on Friday after Bloomberg reported that the drugmaker is exploring options, including the potential sale of the company. Unnamed sources claim that Biohaven has attracted interest from potential bidders.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,